Menu
  • Home
  • London Exchange
  • Euronext
  • Australian Exchange
  • Wire
  • Contact Us
  • Business & Finance
NewsnReleases

Australian Pharmaceutical Industries (API)

Posted on October 11, 2020October 11, 2020

Australian Pharmaceutical Industries (API) is a health and beauty company in Australia that is involved in pharmaceutical distribution, retailing and manufacturing. API is Australia’s largest wholesale distributor of pharmaceutical and allied products.

The company is involved in retailing through company-owned stores and franchise operations. API is listed on the Australian Securities Exchange and operates in the retail health and beauty industry under the following brands: Priceline, Priceline Pharmacy, Soul Pattinson and Pharmacist Advice.  

Traded as:           ASX: API

Industry:              Health and Beauty

Founded:            1910

Headquarters:   New South Wales, Australia

Products:             Pharmaceutical, health and beauty

Services:

  • Wholesale distribution
  • Manufacturing
  • Retailing

Subsidiaries:

  • Priceline
  • Priceline Pharmacy
  • Soul Pattinson
  • Pharmacists Advice

Website:              www.api.net.au

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Track all markets on TradingView

Investing.com .

Site Navigation

  • Home
  • Listed Companies
  • Contact Us
  • London Stock Exchange
  • Singapore Exchange
  • Canadian Exchange
  • Australian Exchange
  • Oslo Bourse
  • PSX
  • Ratings
  • Euronext
  • MENA
  • Nasdaq Nordic
  • Wire
  • Business & Finance
  • Gadget Reviews
  • About Us: A Comprehensive Financial News Database

All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.

Listed Companies

Equity Markets and Stock Exchanges

NNR

©2025 NewsnReleases | WordPress Theme by Superb WordPress Themes